Clinical Trial

A Modified Platform Trial of Multiple CAMPs for the Management of Diabetic Foot Ulcers and Venous Leg Ulcers

Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
The purpose of this study is to determine how well multiple CAMPs (Cellular, Acellular and Matrix-Like Products) and Standard of Care work when compared to Standard of Care alone in achieving complete closure of hard-to-heal diabetic foot and venous leg ulcers.
Protocol Amendment History 1 change
notable Trial sites reduced: 15 -> 12 locations 2026-04-15
Trial Details
NCT Number NCT06453187
Lead Sponsor Integra LifeSciences Corporation
Collaborators: SerenaGroup, Inc.
Conditions Diabetic Foot Ulcer, Venous Leg Ulcer
Enrollment 350 participants
Start Date 2024-11-18
Primary Completion 2026-12-31 (estimated)
Study Completion 2027-03-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-27